Isolation of rat dihydrofolate reductase gene and characterization of recombinant enzyme

被引:16
作者
Wang, YH
Bruenn, JA
Queener, SF
Cody, V
机构
[1] Hauptman Woodward Med Res Inst, Struct Biol Dept, Buffalo, NY 14203 USA
[2] Indiana Univ, Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA
关键词
D O I
10.1128/AAC.45.9.2517-2523.2001
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
While assays of many antifolate inhibitors for dihydrofolate reductase (DHFR) have been performed using rat DHFR as a target, neither the sequence nor the structure of rat DHFR is known. Here, we report the isolation of the rat DHFR gene through screening of a rat liver cDNA library. The rat liver DHFR gene has an open reading frame of 561 bp encoding a protein of 187 amino acids. Comparisons of the rat enzyme with those from other species indicate a high level of conservation at the primary sequence level and more so for the amino acid residues comprising the active site of the enzyme. Expression of the rat DHFR gene in bacteria produced a recombinant protein with high enzymatic activity. The recombinant protein also paralleled the human enzyme with respect to the inhibition by most of the antifolates tested with PT652 and PT653 showing a reversal in their patterns. Our results indicated that rat DHFR can be used as a model to study antifolate compounds as potential drug candidates. However, variations between rat and human DHFR enzymes, coupled with unique features in the inhibitors, could lead to the observed differences in enzyme sensitivity and selectivity.
引用
收藏
页码:2517 / 2523
页数:7
相关论文
共 55 条
[41]   CRYSTAL-STRUCTURE OF HUMAN DIHYDROFOLATE-REDUCTASE COMPLEXED WITH FOLATE [J].
OEFNER, C ;
DARCY, A ;
WINKLER, FK .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1988, 174 (02) :377-385
[42]   Lipophilic antifolates as agents against opportunistic infections .1. Agents superior to trimetrexate and piritrexim against Toxoplasma gondii and Pneumocystis carinii in in vitro evaluations [J].
Piper, JR ;
Johnson, CA ;
Krauth, CA ;
Carter, RL ;
Hosmer, CA ;
Queener, SF ;
Borotz, SE ;
Pfefferkorn, ER .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (06) :1271-1280
[43]   EXPRESSION AND SITE-DIRECTED MUTAGENESIS OF HUMAN DIHYDROFOLATE-REDUCTASE [J].
PRENDERGAST, NJ ;
DELCAMP, TJ ;
SMITH, PL ;
FREISHEIM, JH .
BIOCHEMISTRY, 1988, 27 (10) :3664-3671
[44]   NEW DRUG DEVELOPMENTS FOR OPPORTUNISTIC INFECTIONS IN IMMUNOSUPPRESSED PATIENTS - PNEUMOCYSTIS CARNII [J].
QUEENER, SF .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (24) :4739-4759
[45]   Nonclassical 2,4-diamino-5-aryl-6-ethylpyrimidine antifolates: Activity as inhibitors of dihydrofolate reductase from Pneumocystis carinii and Toxoplasma gondii and as antitumor agents [J].
Robson, C ;
Meek, MA ;
Grunwaldt, JD ;
Lambert, PA ;
Queener, SF ;
Schmidt, D ;
Griffin, RJ .
JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (19) :3040-3048
[46]   Structure-based design of selective inhibitors of dihydrofolate reductase: Synthesis and antiparasitic activity of 2,4-diaminopteridine analogues with a bridged diarylamine side chain [J].
Rosowsky, A ;
Cody, V ;
Galitsky, N ;
Fu, HN ;
Papoulis, AT ;
Queener, SF .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (23) :4853-4860
[47]  
Rosowsky A, 1989, Prog Med Chem, V26, P1, DOI 10.1016/S0079-6468(08)70241-8
[48]  
Rosowsky A, 1999, Drug Des Discov, V16, P25
[49]  
Sambrook J., 1989, MOL CLONING
[50]  
Sirawaraporn W, 1991, Protein Expr Purif, V2, P313, DOI 10.1016/1046-5928(91)90088-Z